Medical cannabis strain names can be useful labels, but they are not medical instructions. A name such as Blue Dream, Wedding Cake or OG Kush does not tell you whether a prescribed cannabis product is suitable for you, how it will affect you, or whether it is similar enough to another product with the same name.
For UK patients, the safe rule is simple: treat the name as an identifier, not as treatment advice.
What matters more is the exact product you have been prescribed, the THC and CBD content, the form, the batch, the pharmacy label, any clinic instructions, and how your prescriber wants you to monitor response and side effects.
Why strain names are not a treatment plan
Many strain names come from breeding history, older cannabis culture, brand choices or market shorthand. They can make products feel familiar, but they do not work like a licensed medicine name or a clinical indication.
Two products can share a familiar strain name and still differ in ways that matter for patient understanding. Cultivation, processing, batch variation, supplier specification and the measured cannabinoid or terpene profile can all affect what is actually in the product.
Peer-reviewed research on commercial cannabis has found that strain-name labels do not reliably map to clear chemical categories. One large US analysis found that commercial strain names were associated with variable chemical consistency across products. Genetic research has also found that some samples sold under the same strain name were not genetically consistent.
Those studies are not UK prescribing rules. They are useful caution: the name alone is too weak a basis for medical decisions.
What to look at instead
If you are trying to understand a prescribed product, start with the information that is tied to your prescription and supply.
Useful details include:
- the product name on the prescription and pharmacy label;
- the form, such as flower, oil, capsule or extract;
- the declared THC and CBD content, where relevant;
- the batch number and expiry date;
- storage instructions and any pharmacy warnings;
- the clinic’s instructions for use and monitoring;
- any certificate of analysis or batch document supplied by the pharmacy or clinic.
This information still does not tell you what to choose. Product suitability, route, amount, timing and monitoring sit with your prescriber. But it gives you a better basis for asking precise questions than the strain name alone.
For label basics, read how to read a medical cannabis prescription label. For batch paperwork, read batch numbers and certificates of analysis in medical cannabis.
Why indica, sativa and hybrid can also mislead
Patients may also see products described as indica, sativa or hybrid. These words are widely used, but they should not be treated as a reliable prediction of clinical effect.
The problem is similar to strain names. The label may describe plant ancestry, growth habit or market convention, but it does not replace the product’s measured profile or your clinical context. A patient cannot safely infer suitability, impairment risk, symptom response or side-effect risk from indica or sativa wording alone.
If those labels appear on a product page or clinic document, use them as background context only. Ask what is known about the actual product you have been prescribed.
Read more in indica, sativa and hybrid: useful labels or oversimplification?.
Terpenes and minor cannabinoids need careful wording
Terpenes and minor cannabinoids are part of cannabis science, and they may be listed on some product or batch documents. They can be useful for describing a plant profile, smell or formulation context.
They should not be turned into patient rules such as “this terpene means this effect” or “this minor cannabinoid is right for this condition”. NICE, NHS England, GMC and CQC guidance all keep prescribing responsibility with appropriately qualified clinicians and stress individual assessment, licensing status, evidence, safety, interactions and monitoring.
That does not mean patients should ignore product information. It means the right question is not “Which strain name should I ask for?” but “What does this product information mean for my prescription, risks and monitoring?”
Questions to ask your clinic or pharmacy
If a strain name is confusing, ask direct questions tied to your prescription.
Useful questions include:
- Is this the exact product my prescriber intended?
- What are the declared THC and CBD details for this product or batch?
- Is this a licensed product, or an unlicensed cannabis-based medicinal product supplied for my individual prescription?
- Is there a batch document or certificate of analysis for this supply?
- How should I record response, side effects or concerns before my next review?
- Who should I contact if the product name, label, batch or appearance does not match what I expected?
Avoid asking a clinic to match a product just because a name sounds familiar. A better question is whether the current prescription, formulation and monitoring plan still fit your clinical needs.
What not to assume
Do not assume that:
- the same strain name means the same product;
- a stronger-sounding name means a stronger medicine;
- indica, sativa or hybrid predicts how you will feel;
- terpene wording is a treatment plan;
- a previous non-prescribed experience predicts suitability under medical care;
- a product name tells you whether driving, work, travel or side-effect questions are settled.
NHS guidance is clear that prescribed medical cannabis should be kept in its original packaging with the dispensing label, and that side effects should be raised with the medical team. NICE also says prescribers should discuss benefits, harms, licensing status, interactions, driving and travel considerations before prescribing cannabis-based medicinal products.
Keep it practical
Strain names can help you identify what people are talking about. They can also help MCPH organise strain pages and patient literacy articles.
But they are not enough for medical decision-making.
If the name, label or product profile raises a question, take it to the clinic or pharmacy. Keep the conversation about the exact supplied product, the batch, your prescription, your records, your side effects and your follow-up plan.
Read next
- How to read a medical cannabis prescription label
- Batch numbers and certificates of analysis in medical cannabis
- Indica, sativa and hybrid: useful labels or oversimplification?
- Medical cannabis strains
Sources
- NHS: Medical cannabis
- NICE: Cannabis-based medicinal products guideline NG144
- NHS England: Cannabis-based products for medicinal use
- GMC: Information for doctors on cannabis-based products for medicinal use
- CQC: Cannabis-based medicinal products
- Smith CJ, Vergara D, Keegan B and Jikomes N: The phytochemical diversity of commercial Cannabis in the United States
- Jikomes N and Zoorob M: The cannabinoid content of legal cannabis in Washington State varies systematically across testing facilities and popular consumer products
- Schwabe AL and McGlaughlin ME: Genetic tools weed out misconceptions of strain reliability in Cannabis sativa
